APC p.Ser634Arg
c.1902T>G · rs876659460 · VCV231954
ClinGen expert panel — InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP
Uncertain Significance for familial adenomatous polyposis 1. Applied ACMG criteria (verbatim):
PM2_Supporting BP1
Curation rationale (ClinGen, verbatim)
The NM_000038.6(APC):c.1902T>G (p.Ser634Arg) variant in APC is a missense variant predicted to cause substitution of Serine by Arginine at amino acid position 634 (p.Ser634Arg). This variant has been reported in 1 proband meeting phenotypic criteria, resulting in a total phenotype score of 0.5 (PS4 not met [Ambry]). The variant has been reported in 1 additional proband with a colorectal cancer/polyposis associated phenotype not meeting phenotypic criteria (PMID: 27696107). The total minor allele frequency in gnomAD v2.1.1 (non-cancer) is 0.0004% (1/236788 alleles), which is lower than the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP (HCCP VCEP) threshold < 0.001% (0.00001) for PM2_Supporting if the allele count is ≤ 1 and therefore meets this criterion (PM2_Supporting). RT-PCR of cDNA and mini-gene splicing assays demonstrated that the variant impacts splicing by skipping of exon 15 resulting in a premature stop codon (PMID: 24599579). However, since alternative splicing/skipping of this exon is known and in PMID: 24599579 no pronounced skipping compared to controls is described, PS3 is not applicable. Moreover, the results from ≥ 2 in silico splicing predictors (SpliceAI and MaxEntScan) support that this variant does not affect splicing. APC, in which the variant was identified, is defined by the HCCP VCEP as a gene for which primarily truncating variants are known to cause disease (BP1). Due to conflicting evidence, this variant is a variant of uncertain significance (VUS) for autosomal-dominant inherited FAP based on the ACMG/AMP criteria applied, as specified by the HCCP VCEP: PM2_Supporting, BP1 (VCEP specifications version v2.0.3; date of approval 7/24/2023).
ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9995 | likely pathogenic · top 1% in APC |
|---|---|---|
| REVEL | 0.452 | indeterminate |
| SaProt | — | not scored · why |
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 0.66 | GERP -1.9, phastCons 1 |
| Regional constraint | o/e 0.74 | unconstrained · MANE · 11 kb · p 4.8e-05 · regional, not allelic |
| Overall | ||
| CADD | 23.3 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL is an independent agreement signal.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- APC
- Protein
- p.Ser634Arg
- Coding
- c.1902T>G
- MANE Select
- NM_000038
- dbSNP
- rs876659460
- Type
- single nucleotide variant
- Location
- chr5:112835109 (GRCh38)
- Gene constraint
- LOEUF 0.321 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
- Residue 634
- an α-helix
Disease context
familial adenomatous polyposis 1 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: hereditary neoplastic syndrome
For Familial adenomatous polyposis (Orphanet):
- Inheritance
- Autosomal dominant, Autosomal recessive
- Onset
- Adult
- Prevalence
- 1-9 / 100 000 (Worldwide)
Similar variants
- APC p.Ser634Asn Uncertain significance ★ ⚠ same residue
- APC p.Ser634Ile Uncertain significance ★ same residue
- APC p.Ser634= Benign ★ same residue
- APC p.Ser634fs Pathogenic ★★★ same residue
- APC c.1312+3A>C Likely pathogenic ★★★ same condition
- APC c.1312+3A>G Pathogenic ★★★ same condition
- APC c.1312+5G>A Likely pathogenic ★★★ same condition
- APC c.1312+5G>C Likely pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/apc-p-ser634arg (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown